Clinical Trial Update: Capecitabine and Bevacizumab ± Vinorelbine in Metastatic Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating capecitabine and bevacizumab with or without vinorelbine in metastatic breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Avastin (bevacizumab)
• Navelbine (vinorelbine)
• Xeloda (capecitabine)

Snippet

Sponsor: iOMEDICO AG | Conditions: Metastatic Breast Cancer | Phase 3 | Status: COMPLETED